000 01527 a2200421 4500
005 20250516132514.0
264 0 _c20130405
008 201304s 0 0 eng d
022 _a2163-0763
024 7 _a10.1097/TA.0b013e31827e2410
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWafaisade, Arasch
245 0 0 _aAdministration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge.
_h[electronic resource]
260 _bThe journal of trauma and acute care surgery
_cFeb 2013
300 _a387-3; discussion 393-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aExsanguination
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFibrinogen
_xadministration & dosage
650 0 4 _aHemostatics
_xadministration & dosage
650 0 4 _aHospital Mortality
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aSurvival Analysis
650 0 4 _aTime Factors
650 0 4 _aWounds and Injuries
_xcomplications
700 1 _aLefering, Rolf
700 1 _aMaegele, Marc
700 1 _aBrockamp, Thomas
700 1 _aMutschler, Manuel
700 1 _aLendemans, Sven
700 1 _aBanerjee, Marc
700 1 _aBouillon, Bertil
700 1 _aProbst, Christian
773 0 _tThe journal of trauma and acute care surgery
_gvol. 74
_gno. 2
_gp. 387-3; discussion 393-5
856 4 0 _uhttps://doi.org/10.1097/TA.0b013e31827e2410
_zAvailable from publisher's website
999 _c22451906
_d22451906